06.19.14
National Cheng Kung University (NCKU) of Taiwan, alongside five Global Academia-Industry Alliance (GAIA) members, have signed an agreement with the University of Malaya (Kuala Lampur, Malaysia) and the university’s spin-off company, BioApps Sdn. Bhd., to form a collaboration of innovative research and development, clinical trials, training and education, and services in the fields of medical devices and bioengineering.
The agreement will allow the Taiwanese medical device industry to penetrate the Malaysian market, opening a brand new channel for marketing Taiwanese medical devices and equipment to Asia and the rest of the world.
According to the parties involved, this collaboration not only will help overcome problems faced by Taiwanese brands in the international market, but also create better economic benefits and impacts through academic innovation, leading research and evidence-based clinical trials.
The agreement states that the six participating Taiwanese medical device manufacturers will be able to market and sell their products, including medical equipment and rehabilitation aids, to Malaysia via BioApps under collaborated, evidence-based clinical trials and research. All the parties involved will also collaborate in building brands and expanding in the Southeast Asian market.
Future plans including the establishment and expansion of collaborative relationships with key opinion leaders at top university hospitals in order to promote and market Taiwanese medical devices to Southeast Asia, India, Russia and the rest of the world.
The NCKU Medical Device Innovation Center, led by Director Fong-Chin Su, chose Malaysia as the first base of Taiwan’s medical devices mainly because of the close relationships established between NCKU and many other Southeast and South Asian universities through the Presidents’ Forum of Southeast and South Asia and Taiwan Universities (SATU).
The agreement will allow the Taiwanese medical device industry to penetrate the Malaysian market, opening a brand new channel for marketing Taiwanese medical devices and equipment to Asia and the rest of the world.
According to the parties involved, this collaboration not only will help overcome problems faced by Taiwanese brands in the international market, but also create better economic benefits and impacts through academic innovation, leading research and evidence-based clinical trials.
The agreement states that the six participating Taiwanese medical device manufacturers will be able to market and sell their products, including medical equipment and rehabilitation aids, to Malaysia via BioApps under collaborated, evidence-based clinical trials and research. All the parties involved will also collaborate in building brands and expanding in the Southeast Asian market.
Future plans including the establishment and expansion of collaborative relationships with key opinion leaders at top university hospitals in order to promote and market Taiwanese medical devices to Southeast Asia, India, Russia and the rest of the world.
The NCKU Medical Device Innovation Center, led by Director Fong-Chin Su, chose Malaysia as the first base of Taiwan’s medical devices mainly because of the close relationships established between NCKU and many other Southeast and South Asian universities through the Presidents’ Forum of Southeast and South Asia and Taiwan Universities (SATU).